Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

被引:98
作者
Sissung, Tristan M. [2 ]
Baum, Caitlin E. [1 ]
Kirkland, C. Tyler [1 ]
Gao, Rui [1 ]
Gardner, Erin R. [3 ]
Figg, William D. [1 ,2 ]
机构
[1] NCI, Mol Pharmacol Sect, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Clin Pharmacol Program, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[3] NCI, Clin Pharmacol Program, SAIC Frederick, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
ABCB1; ABCC1; ABCC2; ABCG2; OATP1B3; OATP1B1; Pharmacogenetics; Membrane transporters; SINGLE NUCLEOTIDE POLYMORPHISMS; CANCER RESISTANCE PROTEIN; HUMAN MDR1 GENE; OATP1B1; OATP-C; P-GLYCOPROTEIN; ORGANIC ANION; IN-VITRO; ORAL BIOAVAILABILITY; FUNCTIONAL-CHARACTERIZATION; MULTIDRUG TRANSPORTERS;
D O I
10.1007/s12033-009-9220-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review provides an overview of the pharmacogenetics of membrane transporters including selected ABC transporters (ABCB1, ABCC1, ABCC2, and ABCG2) and OATPs (OATP1B1 and OATP1B3). Membrane transporters are heavily involved in drug clearance and alters drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have significant effects on the absorption, distribution, metabolism and excretion of compounds, and may alter pharmacodynamics of many agents. This review discusses the techniques used to identify substrates and inhibitors of these proteins and subsequently to assess the effect of genetic mutation on transport, both in vitro and in vivo. A comprehensive list of substrates for the major drug transporters is included. Finally, studies linking transporter genotype with clinical outcomes are discussed.
引用
收藏
页码:152 / 167
页数:16
相关论文
共 50 条
[31]   ABC membrane transporters and their multifunctional nature [J].
Smolik, Magdalena ;
Suraj, Joanna ;
Kurpinska, Anna ;
Walczak, Maria .
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 :606-622
[33]   An update on efflux and uptake transporters as determinants of statin response [J].
Cunha e Rocha, Karina ;
Veloso Pereira, Beatriz Maria ;
Rodrigues, Alice Cristina .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (06) :613-624
[34]   Expression, regulation and function of intestinal drug transporters: an update [J].
Mueller, Janett ;
Keiser, Markus ;
Drozdzik, Marek ;
Oswald, Stefan .
BIOLOGICAL CHEMISTRY, 2017, 398 (02) :175-192
[35]   Update on the pharmacogenetics of the vitamin D receptor and osteoporosis [J].
Gennari, Luigi ;
Merlotti, Daniela ;
De Paola, Vincenzo ;
Martini, Giuseppe ;
Nuti, Ranuccio .
PHARMACOGENOMICS, 2009, 10 (03) :417-433
[36]   Pharmacogenetics of human androgens and prostate cancer - an update [J].
Novelli, G ;
Margiotti, K ;
Chiocca, AM ;
Spera, E ;
Micali, F ;
Reichardt, JKV .
PHARMACOGENOMICS, 2004, 5 (03) :283-294
[37]   Pharmacogenetics of alcohol use disorder treatments: an update [J].
Hartwell, Emily E. ;
Kranzler, Henry R. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (07) :553-564
[38]   Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update [J].
Ling, Stephanie F. ;
Bluett, James .
PHARMACOGENOMICS, 2020, 21 (01) :3-6
[39]   Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin [J].
Hemauer, Sarah J. ;
Patrikeeva, Svetlana L. ;
Nanovskaya, Tatiana N. ;
Hankins, Gary D. V. ;
Ahmed, Mahmoud S. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (04) :383.e1-383.e7
[40]   Polyamines and membrane transporters [J].
Ahmed A. Abdulhussein ;
Heather M. Wallace .
Amino Acids, 2014, 46 :655-660